TCL-1B3a Inhibitors
TCL-1B3a inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the TCL-1B3a protein, which is part of the TCL1 family. This family of proteins is involved in regulating intracellular signaling pathways that govern key cellular processes such as proliferation, differentiation, and survival. TCL-1B3a, like other members of the TCL1 family, interacts with signaling molecules involved in pathways such as the PI3K (phosphoinositide 3-kinase) pathway. The PI3K pathway is crucial for various cellular functions, including metabolism, growth, and survival, making TCL-1B3a an important player in regulating these processes. Inhibition of TCL-1B3a disrupts these protein interactions, leading to alterations in signaling dynamics and cellular responses.
Research using TCL-1B3a inhibitors provides important insights into the molecular mechanisms underlying cellular regulation and signaling. By blocking the activity of TCL-1B3a, researchers can investigate how this protein contributes to the regulation of signal transduction pathways and its role in controlling the balance between cell growth and cell death. Inhibiting TCL-1B3a also enables the study of its specific role within the broader TCL1 protein family, providing a clearer understanding of how individual family members modulate different aspects of cellular physiology. These inhibitors are valuable for exploring the complexities of cellular communication and for dissecting how protein interactions within the PI3K and other related pathways contribute to maintaining cellular homeostasis. Through the study of TCL-1B3a inhibitors, scientists gain a deeper understanding of the regulation of cell behavior and the interconnected signaling networks that influence cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can inhibit a wide range of protein kinases which may be upstream regulators or direct activators of TCL-1B3a. By inhibiting these kinases, Staurosporine would prevent phosphorylation events necessary for TCL-1B3a activation or interaction with other cellular components. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. Given that PI3K signaling can regulate a variety of cellular functions including those related to TCL-1B3a, inhibition by LY294002 can lead to a decrease in the PI3K-dependent activation of downstream effectors that might be necessary for TCL-1B3a function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can inhibit the MAPK/ERK pathway. ERK has been implicated in various signal transduction processes, and its inhibition can lead to reduced phosphorylation and activation of proteins associated with TCL-1B3a, thereby functionally inhibiting TCL-1B3a through disruption of its signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Since JNK is involved in stress and apoptotic pathways that can interact with or regulate TCL-1B3a, inhibition of JNK by SP600125 can lead to a reduction in JNK-mediated activation of molecular mechanisms that would otherwise enhance the function of TCL-1B3a. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor, and p38 MAP kinase is involved in inflammatory responses and stress-induced signaling pathways. Inhibition of p38 by SB203580 can lead to reduced activation of signaling cascades that TCL-1B3a might be a part of, resulting in the functional inhibition of TCL-1B3a. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor like LY294002, but with a different chemical structure. By inhibiting PI3K activity, Wortmannin can suppress downstream signaling necessary for TCL-1B3a function, leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, similar to PD98059, but with a different structure. It prevents the activation of MAPK/ERK pathway, which could be essential for the activation or stabilization of TCL-1B3a, thus leading to functional inhibition of TCL-1B3a. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor and by inhibiting mTOR, which is a central regulator of cell growth and proliferation, it can indirectly lead to the functional inhibition of TCL-1B3a, assuming TCL-1B3a is involved in pathways regulated by mTOR. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X is a protein kinase C (PKC) inhibitor. PKC enzymes have roles in various signaling pathways that could intersect with TCL-1B3a function. Therefore, inhibition of PKC by GF109203X can result in the functional inhibition of TCL-1B3a by altering the signaling environment in which TCL-1B3a operates. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. The Aurora kinases are involved in cell cycle regulation, and their inhibition could disrupt processes that are potentially coupled with TCL-1B3a function, leading to its functional inhibition. | ||||||